Finance

Lists
ALM:BME
Almirall SA
10,68 €
-0,93%
(-0,100) 1D
13 қар., 17:36:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALM...
Open
10,70 €
High
10,84 €
Low
10,62 €
Mkt. cap
2,35 млрд
Avg. vol.
141,50 м.
Volume
79,00 мың
Dividend
1,75%
Quarterly dividend
0,05 €
Ex-dividend date
2017 ж. 30 мам.
P/E ratio
38,85
52-wk high
13,98 €
52-wk low
9,81 €
EPS
0,27 €
Shares outstanding
217,78 млн
No. of employees
2 мың
Open
10,70 €
High
10,84 €
Low
10,62 €
Mkt. cap
2,35 млрд
Avg. vol.
141,50 м.
Volume
79,00 мың
Dividend
1,75%
Quarterly dividend
0,05 €
Ex-dividend date
2017 ж. 30 мам.
P/E ratio
38,85
52-wk high
13,98 €
52-wk low
9,81 €
EPS
0,27 €
Shares outstanding
217,78 млн
No. of employees
2 мың
News stories
From web sources and news partners
Profile
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology. With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
About Almirall SA
CEOGianfranco Nazzi | Carlos Gallardo Piqué
Employees2,1 мың
Founded1944
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
2026 ж. 09 қар.
Fiscal period
Q3 2026
- / 0,08 €
Revenue / Est. (EUR)
287,98 млн / 292,62 млн
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
288,93 млн
292,40 млн
313,22 млн
287,98 млн
Cost of goods sold
-27,67 млн
104,30 млн
31,26 млн
177,34 млн
Cost of revenue
-27,67 млн
104,30 млн
31,26 млн
177,34 млн
Research and development expenses
-102,40 млн
34,80 млн
-34,80 млн
107,10 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-102,92 млн
121,60 млн
14,88 млн
229,22 млн
Operating expense
310,92 млн
158,10 млн
240,19 млн
74,61 млн
Total operating expenses
283,25 млн
262,40 млн
271,44 млн
251,96 млн
Operating income
5,69 млн
30,00 млн
41,78 млн
36,02 млн
Other non operating income
3,36 млн
-1,70 млн
-2,27 млн
-1,73 млн
EBT including unusual items
9,35 млн
23,40 млн
37,45 млн
21,05 млн
EBT excluding unusual items
5,78 млн
24,50 млн
36,46 млн
30,64 млн
Income tax expense
2,29 млн
8,10 млн
13,20 млн
7,30 млн
Effective tax rate
24,54%
34,62%
35,24%
34,70%
Other operating expenses
365,05 млн
1,70 млн
184,83 млн
-186,43 млн
Net income
7,05 млн
15,30 млн
24,25 млн
13,75 млн
Net profit margin
2,44%
5,23%
7,74%
4,77%
Earnings per share
-
-
-
-
Interest and investment income
1,35 млн
1,00 млн
1,54 млн
1,46 млн
Interest expense
-5,05 млн
-4,50 млн
-4,62 млн
-4,98 млн
Net interest expenses
-3,70 млн
-3,50 млн
-3,08 млн
-3,52 млн
Depreciation and amortization charges
151,18 млн
-
75,28 млн
-75,28 млн
EBITDA
23,70 млн
67,50 млн
69,12 млн
85,08 млн
Gain or loss from assets sale
199,00 м.
-
114,00 м.
-114,00 м.
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары